Method and system for delivering cardiac resynchronization therapy with variable atrio-ventricular delay

• US 8,121,685 B2
• Filed: 11/20/2009
• Issued: 02/21/2012
• Est. Priority Date: 12/22/2003
• Status: Active Grant

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Ding, Jiang, Yu, Yinghong, Morris, Milton M.
• Primary Examiner(s): MANUEL, GEORGE C
• Application Number:
  US12/622,602
• Publication Number:
  US 20100069988A1
• Time in Patent Office: 823 Days
• Field of Search: 607/9
• US Class Current: 607/9
• CPC Class Codes: A61N 1/3627 for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy
• CPC Class Codes: A61N 1/36585 controlled by two or more physical parameters
• CPC Class Codes: A61N 1/3682 with a variable atrioventricular delay
• CPC Class Codes: A61N 1/3684 for stimulating the heart at multiple sites of the ventricle or the atrium
• CPC Class Codes: A61N 1/36842 Multi-site stimulation in the same chamber
• CPC Class Codes: A61N 1/36843 Bi-ventricular stimulation

Abstract

A pacing system computes optimal cardiac resynchronization pacing parameters using intrinsic conduction intervals. In various embodiments, values for atrio-ventricular delay intervals are each computed as a function of an intrinsic atrio-ventricular interval and a parameter reflective of an interventricular conduction delay. Examples of the parameter reflective of the interventricular conduction delay include QRS width and interval between right and left ventricular senses.

Claims

1. A cardiac rhythm management system, comprising:

a plurality of sense amplifiers configured to sense cardiac electrical activity;

a plurality of pulse generators configured to deliver pacing pulses; and

a controller for controlling delivery of the pacing pulses, the controller programmed to;

control delivery of ventricular pacing using a programmable atrio-ventricular delay (AVD) interval in accordance with an atrial tracking or AV sequential pacing mode;

determine a present atrial rate;

vary the AVD interval by setting the AVD interval to an optimum value stored in a table, the optimal value associated with the present atrial rate;

measure an intrinsic conduction parameter;

compute an optimal value for the AVD interval as a linear function of the measured intrinsic conduction parameter; and

initialize or update the table by storing the computed optimal value and an associated atrial rate in the table, the associated atrial rate corresponding to the present atrial rate.

2. The system of claim 1, wherein the controller is programmed to measure an interval between a right atrial sense or pace and a left atrial sense as the intrinsic conduction parameter.

3. The system of claim 1, wherein the controller is programmed to measure an intrinsic atrio-ventricular (AV) interval between an atrial sense or pace and a ventricular sense as the intrinsic conduction parameter.

4. The system of claim 3, wherein the controller is programmed to measure a parameter reflective of an interventricular conduction delay, and the controller is programmed to compute an optimal value for the AVD interval as a linear function of the measured intrinsic AV interval and the parameter reflective of an interventricular conduction delay.

5. The system of claim 4, wherein the controller is programmed to measure an interval between right and left ventricular senses as the parameter reflective of an interventricular conduction delay.

6. The system of claim 1, wherein coefficients of the linear function and the intrinsic conduction parameter are derived from a linear regression analysis of clinical population data relating different values of the intrinsic conduction parameter to an optimum AVD interval for delivering cardiac resynchronization therapy as determined by measurement of a cardiac function parameter.

7. The system of claim 6, wherein the optimum AVD interval for delivering cardiac resynchronization therapy is indicated by a measured maximum value of the cardiac function parameter.

8. The system of claim 7, wherein the cardiac function parameter comprises at least one of a left ventricular pressure change, an arterial pulse pressure, and a measure of cardiac output.

9. The system of claim 1, wherein the controller is programmed to vary the AVD interval by interpolating between two optimum AVD values stored in the table which have associated atrial rates above and below the present atrial rate, if there is no associated atrial rate in the table corresponding to the present atrial rate.

10. The system of claim 1, comprising an implantable device including the plurality of sense amplifiers, the plurality of pulse generators, and the controller.

11. The device of claim 1, comprising setting the AVD interval by interpolating between two optimum AVD values stored in the table which have associated atrial rates above and below the present atrial rate, if there is no associated atrial rate in the table corresponding to the present atrial rate.

12. A method for operating an implantable cardiac rhythm management device, comprising:

sensing cardiac electrical activity using the implantable cardiac rhythm management device;

delivering pacing pulses from the implantable cardiac rhythm management device;

controlling the delivering pacing pulses using a programmable atrio-ventricular delay (AVD) interval in accordance with an atrial tracking or AV sequential pacing mode;

determining a present atrial rate using the sensed cardiac electrical activity;

setting the AVD interval to an optimum value stored in a table, the optimal value associated with the present atrial rate;

measuring at least one intrinsic conduction parameter using the sensed cardiac electrical activity;

computing an optimal value for the AVD interval as a linear function of the measured at least one intrinsic conduction parameter; and

initialize or update the table by storing the computed optimal value and an associated atrial rate in the table, the associated atrial rate corresponding to the present atrial rate.

13. The method of claim 12, wherein measuring the at least one intrinsic conduction parameter comprises measuring a first interval between a right atrial sense or pace and a left atrial sense.

14. The method of claim 12, wherein measuring the at least one intrinsic conduction parameter comprises measuring a first interval between an interval between an atrial sense or pace and a ventricular sense.

15. The method of claim 14, wherein measuring the at least one intrinsic conduction parameter comprises measuring a second interval between right and left ventricular senses, and computing the optimal value for the AVD interval comprises computing an optimal value for the AVD interval as a linear function of the measured first and second intervals.

16. The method of claim 12, comprising deriving coefficients for the linear function from a linear regression analysis of clinical population data relating different values of the intrinsic conduction parameter to an optimum AVD interval for delivering cardiac resynchronization therapy as determined by measurement of a cardiac function parameter.

17. The method of claim 16, wherein the optimum AVD interval for delivering cardiac resynchronization therapy is indicated by a measured maximum value of the cardiac function parameter.

18. The method of claim 17, wherein the cardiac function parameter comprises a left ventricular pressure change.

19. The method of claim 17, wherein the cardiac function parameter comprises an arterial pulse pressure.

20. The method of claim 17, wherein the cardiac function parameter comprises a measure of cardiac output.